🚀 VC round data is live in beta, check it out!
CS Diagnostics Valuation Multiples
Discover revenue and EBITDA valuation multiples for CS Diagnostics and similar public comparables like Harvard Bioscience, Vivos, BrainCool, Myomo and more.
CS Diagnostics Overview
About CS Diagnostics
CS Diagnostics Corp is a pharmaceutical international wholesaler and manufacturer of medical technology. The current management has been supplying national and international specialists, practices, clinics as well as ministries of health. Its focus is on improving therapy results and reducing its side effects.
Founded
1996
HQ
Employees
16
Website
Sectors
Financials (FY)
EV
$32M
CS Diagnostics Financials
CS Diagnostics reported last fiscal year revenue of — and EBITDA of $71K.
In the same fiscal year, CS Diagnostics generated $71K in EBITDA and $71K in net income.
CS Diagnostics P&L
In the most recent fiscal year, CS Diagnostics reported revenue of — and EBITDA of $71K.
CS Diagnostics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | $71K | XXX | XXX | XXX |
| Net Profit | — | XXX | $71K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
CS Diagnostics Stock Performance
CS Diagnostics has current market cap of $32M, and enterprise value of $32M.
Market Cap Evolution
CS Diagnostics' stock price is $0.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $32M | $32M | 30.0% | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCS Diagnostics Valuation Multiples
CS Diagnostics trades at 455.2x EV/EBITDA.
CS Diagnostics Financial Valuation Multiples
As of April 21, 2026, CS Diagnostics has market cap of $32M and EV of $32M.
Equity research analysts estimate CS Diagnostics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CS Diagnostics has a P/E ratio of 456.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $32M | XXX | $32M | XXX | XXX | XXX |
| EV (current) | $32M | XXX | $32M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 455.2x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 455.2x | XXX | XXX | XXX |
| P/E | — | XXX | 456.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 5135.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CS Diagnostics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
CS Diagnostics Margins & Growth Rates
CS Diagnostics' revenue in the last fiscal year grew by —.
CS Diagnostics' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $-0.0M for the same period.
CS Diagnostics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 9259% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $-0.0M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
CS Diagnostics Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| CS Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Harvard Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivos | XXX | XXX | XXX | XXX | XXX | XXX |
| BrainCool | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| Theraclion | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CS Diagnostics M&A Activity
CS Diagnostics acquired XXX companies to date.
Last acquisition by CS Diagnostics was on XXXXXXXX, XXXXX. CS Diagnostics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by CS Diagnostics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCS Diagnostics Investment Activity
CS Diagnostics invested in XXX companies to date.
CS Diagnostics made its latest investment on XXXXXXXX, XXXXX. CS Diagnostics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by CS Diagnostics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CS Diagnostics
| When was CS Diagnostics founded? | CS Diagnostics was founded in 1996. |
| Where is CS Diagnostics headquartered? | CS Diagnostics is headquartered in United States. |
| How many employees does CS Diagnostics have? | As of today, CS Diagnostics has over 16 employees. |
| Is CS Diagnostics publicly listed? | Yes, CS Diagnostics is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of CS Diagnostics? | CS Diagnostics trades under CSDX ticker. |
| When did CS Diagnostics go public? | CS Diagnostics went public in 2004. |
| Who are competitors of CS Diagnostics? | CS Diagnostics main competitors are Harvard Bioscience, Vivos, BrainCool, Myomo. |
| What is the current market cap of CS Diagnostics? | CS Diagnostics' current market cap is $32M. |
| Is CS Diagnostics profitable? | No, CS Diagnostics is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.